Evidence map›Paper›PMID 21610165›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Characterization of a canine homolog of hepatitis C virus.

Amit Kapoor, Peter Simmonds, Gisa Gerold, Natasha Qaisar, Komal Jain, Jose A Henriquez, Cadhla Firth, David L Hirschberg, Charles M Rice, Shelly Shields and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 278 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Identification of claudin-3 as an entry factor for rat hepacivirus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. A novel genotype ofFrontiers in cellular and infection microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Amit KapoorCenter for Infection and Immunity, Columbia University, New York, NY 10032, USA. ak3117@columbia.edu
Peter Simmonds
Gisa Gerold
Natasha Qaisar
Komal Jain
Jose A Henriquez
Cadhla Firth
David L Hirschberg
Charles M Rice
Shelly Shields
W Ian Lipkin
Columbia University · USRockefeller University · USCentre for Immunity, Infection and Evolution · GBPfizer (United States) · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LIPKIN, W. IAN · 2003 to 2014
$100.8M
Development of Complement Modulating Therapeutics for AMDR24EY017404 · NEI · UNIVERSITY OF UTAH · PI HAGEMAN, GREGORY S · 2006 to 2010
$14.8M
Identification and characterization of cellular factors involved in HCV entryR01AI072613 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2007 to 2016
$4.7M
Viral Arrays for BiodefenseU01AI070411 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2006 to 2010
$4.4M
Risk of Viral Emergence from BatsR01AI079231 · NIAID · ECOHEALTH ALLIANCE, INC. · PI DASZAK, PETER · 2008 to 2012
$2.6M
Simianizing hepatitis C: Defining the species-tropism of a hepatotropic virusR01AI090055 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2010 to 2014
$2.1M
Molecular Characterization of Novel AstrovirusesR21AI090196 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KAPOOR, AMIT · 2010 to 2011
$454k
NEI NIH HHS EY017404NEI NIH HHS R24 EY017404NIAID NIH HHS AI070411NIAID NIH HHS AI072613NIAID NIH HHS AI079231NIAID NIH HHS AI090055NIAID NIH HHS AI090196NIAID NIH HHS AI57158NIAID NIH HHS R01 AI072613NIAID NIH HHS R01 AI079231NIAID NIH HHS R01 AI090055NIAID NIH HHS R21 AI090196NIAID NIH HHS U01 AI070411NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

An estimated 3% of the world's population is chronically infected with hepatitis C virus (HCV). Although HCV was discovered more than 20 y ago, its origin remains obscure largely because no closely related animal virus homolog has been identified; furthermore, efforts to understand HCV pathogenesis have been hampered by the absence of animal models other than chimpanzees for human disease. Here we report the identification in domestic dogs of a nonprimate hepacivirus. Comparative phylogenetic analysis of the canine hepacivirus (CHV) confirmed it to be the most genetically similar animal virus homolog of HCV. Bayesian Markov chains Monte Carlo and associated time to most recent common ancestor analyses suggest a mean recent divergence time of CHV and HCV clades within the past 500-1,000 y, well after the domestication of canines. The discovery of CHV may provide new insights into the origin and evolution of HCV and a tractable model system with which to probe the pathogenesis, prevention, and treatment of diseases caused by hepacivirus infection.

Indexed as

Adenoviruses, CanineAmino Acid SequenceAnimalsBase SequenceConserved SequenceDogsEvolution, MolecularGenome, ViralHepacivirusHepatitis, Infectious CanineHumansMolecular Sequence DataNucleic Acid ConformationPhylogenyRNA, ViralSequence Homology, Amino AcidRNA, ViralViral Envelope Proteins

Identifiers

PMID21610165
PMCPMC3136326
OpenAlexW2037999529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.